Search
for
Sort by
Research 571–600 of 1000+
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Developmental origin of polycystic ovary syndrome - a hypothesis
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- WNT10A Mutations Are a Frequent Cause of a Broad Spectrum of Ectodermal Dysplasias with Sex-Biased Manifestation Pattern in Heterozygotes
- Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
- Metabolic risk in PCOS: phenotype and adiposity impact
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- Defining hirsutism in Chinese women: a cross-sectional study
- Self-organization process in newborn skin organoid formation inspires strategy to restore hair regeneration of adult cells
- Obesity and polycystic ovary syndrome
- Polycystic Ovary Syndrome
- Finasteride
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- Diagnosis of hyperandrogenism: clinical criteria
- Prevalence of polycystic ovaries in women with androgenic alopecia
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Insulin Resistance and Skin Diseases
- Pathways to inflammation: acne pathophysiology
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for <i>In Vivo</i> CRISPR/Cas-Based Genome Editing
- Drug-induced acne
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features